AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27543252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 24336783 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral anticoagulation (OAC) treatment
Number of subjects: 115
Study 24336783 — intervention group
Group type: EXPERIMENTAL
Intervention: OAC treatment in sinus rhythm (SR) subgroup
Number of subjects: 115
Study 24336783 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative OAC use
Number of subjects: 115
Study 24336783 — intervention group
Group type: EXPERIMENTAL
Intervention: Other indications for OAC
Number of subjects: 115
Study 21953589 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 60 mg/day
Number of subjects: 41
Study 21953589 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone 30 mg/day
Number of subjects: 41
Study 21953589 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline)
Number of subjects: 41
Study 19585472 — intervention group
Group type: EXPERIMENTAL
Intervention: Purslane
Number of subjects: 37
Study 19585472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 18301121 — intervention group
Group type: EXPERIMENTAL
Intervention: Active treatments using the Sheehan Disability Scale (SDS)
Number of subjects: 37
Study 18301121 — intervention group
Group type: COMPARATOR
Intervention: Inactive treatments using the Sheehan Disability Scale (SDS)
Number of subjects: 37
Study 15496867 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) >or=50 g
Number of subjects: 140
Study 15496867 — intervention group
Group type: EXPERIMENTAL
Intervention: Other tocolytic
Number of subjects: 140
Study 15496867 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 140
Study 12618255 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual Vacuum Aspiration (MVA)
Number of subjects: 127
Study 12618255 — intervention group
Group type: COMPARATOR
Intervention: Electric Vacuum Aspiration (EVA)
Number of subjects: 127
Study 9474110 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based physical therapy (5 sessions)
Number of subjects: 38
Study 9474110 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional physical therapy strategies incorporated into interactive play activities
Number of subjects: 38
Study 9474110 — intervention group
Group type: COMPARATOR
Intervention: Control group (continued center-based services)
Number of subjects: 38
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU/day, continuously
Number of subjects: 188
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU/day daily for 30 days every other month (cyclically)
Number of subjects: 188
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU/day, continuously
Number of subjects: 188
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 IU/day, ciclically
Number of subjects: 188
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclic and continuous treatment groups at the same dosage
Number of subjects: 188
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 IU/day and 200 IU/day
Number of subjects: 188
Study 7603607 — intervention group
Group type: EXPERIMENTAL
Intervention: S‐calcitonin therapy cessation
Number of subjects: 188
Study 2743348 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg trazodone daily
Number of subjects: 120
Study 2743348 — intervention group
Group type: COMPARATOR
Intervention: 150 mg amitriptyline daily
Number of subjects: 120
Study 2743348 — intervention group
Group type: COMPARATOR
Intervention: 20 mg haloperidol daily
Number of subjects: 120
Study 2743348 — intervention group
Group type: COMPARATOR
Intervention: placebo daily
Number of subjects: 120
Study 31876029 — intervention group
Group type: COMPARATOR
Intervention: Placebo drink (presumed energy drink)
Number of subjects: 20
Study 29222993 — intervention group
Group type: EXPERIMENTAL
Intervention: GABA supplementation
Number of subjects: 0
Study 29222993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28412943 — intervention group
Group type: EXPERIMENTAL
Intervention: PaTH intervention group (n=163)
Number of subjects: 304
Study 28412943 — intervention group
Group type: COMPARATOR
Intervention: Usual care group (n=141)
Number of subjects: 304
Study 26627507 — intervention group
Group type: EXPERIMENTAL
Intervention: Formative Assessment sessions (four sessions over one month)
Number of subjects: 68
Study 26627507 — intervention group
Group type: COMPARATOR
Intervention: Post-intervention summative assessment
Number of subjects: 68
Study 22727979 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined methods group A (all types of training)
Number of subjects: 60
Study 22727979 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy-resistance group B (full-squat)
Number of subjects: 60
Study 22727979 — intervention group
Group type: EXPERIMENTAL
Intervention: Power-oriented group C (parallel-squat)
Number of subjects: 60
Study 22727979 — intervention group
Group type: EXPERIMENTAL
Intervention: Ballistic group D (loaded countermovement jumping)
Number of subjects: 60
Study 22727979 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric group E
Number of subjects: 60
Study 21174533 — intervention group
Group type: EXPERIMENTAL
Intervention: Bendamustine 120 mg/m² on days 1 and 2 of each 21-day cycle for six to eight cycles
Number of subjects: 0
Study 19660462 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg/day)
Number of subjects: 31
Study 19660462 — intervention group
Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 31
Study 19660462 — intervention group
Group type: COMPARATOR
Intervention: Trimethoprim/sulfamethoxazole
Number of subjects: 31
Study 17134849 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg L-dopa plus 100 mg carbidopa (Sinemet CR)
Number of subjects: 189
Study 17134849 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg L-dopa plus 200 mg carbidopa (Sinemet CR)
Number of subjects: 189
Study 17134849 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 189
Study 15170031 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial biopsy (EBB)
Number of subjects: 100
Study 11581044 — intervention group
Group type: EXPERIMENTAL
Intervention: LASIK with Flapmaker microkeratome and Lasersight LSX excimer laser
Number of subjects: 13
Study 9625838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cancer genetic consultation
Number of subjects: 115
Study 9625838 — intervention group
Group type: EXPERIMENTAL
Intervention: Time since cancer diagnosis
Number of subjects: 115
Study 7880610 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous intravenous infusion (c.i.v.) of recombinant human IL-2 (rIL-2)
Number of subjects: 217
Study 7880610 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous (s.c.) injections of recombinant human IL-2 (rIL-2)
Number of subjects: 217
Study 7880610 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutralising activity in patients with anti-rIL-2 antibodies
Number of subjects: 217
Study 7880610 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients receiving at least two cycles of rIL-2 by s.c. injections
Number of subjects: 217
Study 7880610 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of anti-rIL-2 antibodies
Number of subjects: 217
Study 3709639 — intervention group
Group type: EXPERIMENTAL
Intervention: Indenolol
Number of subjects: 12
Study 3709639 — intervention group
Group type: COMPARATOR
Intervention: Propranolol
Number of subjects: 12
Study 29396245 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine (100-200 mg per day for 48 weeks)
Number of subjects: 126
Study 29396245 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (20 Gy in 10-12 fractions over 2-3 weeks)
Number of subjects: 126
Study 29396245 — intervention group
Group type: COMPARATOR
Intervention: Sham radiotherapy and azathioprine (control group)
Number of subjects: 126
Study 29396245 — intervention group
Group type: COMPARATOR
Intervention: Sham radiotherapy and placebo (control group)
Number of subjects: 126
Study 27472526 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement device (MAD)
Number of subjects: 27
Study 27472526 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 27
Study 24858578 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-echo-biofeedback (BFB), 4 sessions conducted by psychologists and a coloproctologist
Number of subjects: 10
Study 24858578 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-echo-biofeedback (BFB)
Number of subjects: 10
Study 24858578 — intervention group
Group type: COMPARATOR
Intervention: Control group (7 patients with normal bowel habits)
Number of subjects: 10
Study 23145381 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalproex extended release (ER)
Number of subjects: 17
Study 23145381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 20230389 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel reintroduction as second-line therapy
Number of subjects: 50
Study 20230389 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel reintroduction
Number of subjects: 50
Study 17894385 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 328
Study 17894385 — intervention group
Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 328
Study 18083475 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous nonangiographic insertion of a venous access device
Number of subjects: 100
Study 18083475 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical cutdown insertion technique
Number of subjects: 100
Study 14730657 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 4.5 microg b.i.d. for 12 weeks
Number of subjects: 302
Study 14730657 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol 9 microg b.i.d. for 12 weeks
Number of subjects: 302
Study 14730657 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 4.5 microg and 9 microg
Number of subjects: 302
Study 10972446 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 8
Study 10972446 — intervention group
Group type: COMPARATOR
Intervention: Nicotine cigarette
Number of subjects: 8
Study 10972446 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 8
Study 10972446 — intervention group
Group type: COMPARATOR
Intervention: Placebo cigarette
Number of subjects: 8
Study 9068935 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline 50 mg/day titrated to 200 mg/day for 32 days
Number of subjects: 20
Study 9068935 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 9068935 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 20
Study 8415898 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.5 mg, P.O.)
Number of subjects: 19
Study 8415898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 3956820 — intervention group
Group type: EXPERIMENTAL
Intervention: Battery-operated iontophoretic device
Number of subjects: 27
Study 30644599 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour feeding interval
Number of subjects: 100
Study 30644599 — intervention group
Group type: COMPARATOR
Intervention: 3-hour feeding interval
Number of subjects: 100
Study 27443570 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated orthogeriatric treatment
Number of subjects: 850
Study 27443570 — intervention group
Group type: COMPARATOR
Intervention: Standard care (historical control)
Number of subjects: 850
Study 25577169 — intervention group
Group type: EXPERIMENTAL
Intervention: Open group (absence of closure)
Number of subjects: 54
Study 25577169 — intervention group
Group type: COMPARATOR
Intervention: Closed group (surgical wound closure)
Number of subjects: 54
Study 23384428 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzogenol (1000 mg/day)
Number of subjects: 60
Study 23384428 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 21356071 — intervention group
Group type: EXPERIMENTAL
Intervention: Singing group
Number of subjects: 100
Study 21356071 — intervention group
Group type: COMPARATOR
Intervention: Usual activities (Control)
Number of subjects: 100
Study 19481310 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat (28% energy), high-complex carbohydrate diet with 1.24g/d LC n-3 PUFA (LFHCC n-3)
Number of subjects: 99
Study 19481310 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat (38% energy), MUFA-rich diet (HMUFA)
Number of subjects: 99
Study 19481310 — intervention group
Group type: COMPARATOR
Intervention: High-fat (38% energy) SFA-rich diet (HSFA)
Number of subjects: 99
Study 19481310 — intervention group
Group type: COMPARATOR
Intervention: Low-fat (28% energy), high-complex carbohydrate diet (LFHCC)
Number of subjects: 99
Study 16756402 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP (video-feedback and brochures to enhance sensitive parenting)
Number of subjects: 81
Study 16756402 — intervention group
Group type: EXPERIMENTAL
Intervention: VIPP-R (video-feedback, brochures, and discussions of mothers' childhood attachment experiences)
Number of subjects: 81
Study 16756402 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study 15120547 — intervention group
Group type: EXPERIMENTAL
Intervention: Second-language speakers
Number of subjects: 0
Study 15120547 — intervention group
Group type: COMPARATOR
Intervention: Native speakers
Number of subjects: 0
Study 12206016 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning
Number of subjects: 32
Study 12206016 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study 9303253 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy group program for headaches; two 90-minute sessions focusing on relaxation, distraction, visualization, and stress management skills.
Number of subjects: 36
Study 9303253 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control condition; treated 5 weeks later.
Number of subjects: 36
Study 9303253 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy group program for headaches; two 90-minute sessions.
Number of subjects: 36
Study 9303253 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up ratings from parents after treatment.
Number of subjects: 36
Study 8314199 — intervention group
Group type: EXPERIMENTAL
Intervention: Semilente (amorphous zinc insulin) injected at bedtime
Number of subjects: 10
Study 8314199 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 10
Study 3084393 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive self-hypnosis training program (6-week duration)
Number of subjects: 30
Study 3084393 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 30
Study 3084393 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive self-hypnosis training program
Number of subjects: 30
Study 31593133 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane block (TAPB)
Number of subjects: 100
Study 31593133 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia (PCIA)
Number of subjects: 100
Study 30044966 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU + GAB
Number of subjects: 99
Study 30044966 — intervention group
Group type: EXPERIMENTAL
Intervention: FLU + MEM
Number of subjects: 99
Study 30044966 — intervention group
Group type: COMPARATOR
Intervention: FLU + PLA
Number of subjects: 99
Study 27094506 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard-dose (SD) group: 40 µg total vaccine dose, 20 µg at weeks 0 and 4
Number of subjects: 114
Study 27094506 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose dose-intensive (HDDI) group: 80 µg total vaccine dose, 40 µg at weeks 0 and 4
Number of subjects: 114
Study 27094506 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose time-intensive (HDTI) group: 80 µg total vaccine dose, 20 µg at weeks 0, 2, 4, and 6
Number of subjects: 114
Study 25058879 — intervention group
Group type: EXPERIMENTAL
Intervention: PDP with ET‐Kyoto solution
Number of subjects: 18
Study 25058879 — intervention group
Group type: EXPERIMENTAL
Intervention: PDP with cold storage/purification stock solution
Number of subjects: 18
Study 25058879 — intervention group
Group type: COMPARATOR
Intervention: non‐PDP (control)
Number of subjects: 18
Study 25058879 — intervention group
Group type: EXPERIMENTAL
Intervention: PDP groups (both solutions)
Number of subjects: 18
Study 21959688 — intervention group
Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 100
Study 21959688 — intervention group
Group type: COMPARATOR
Intervention: TAPP
Number of subjects: 100
Study 20977760 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative sensory testing (QST) in patients
Number of subjects: 60
Study 20977760 — intervention group
Group type: COMPARATOR
Intervention: Control group (30 subjects)
Number of subjects: 60
Study 18375417 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-weighing frequency (≥1/week)
Number of subjects: 5145
Study 18375417 — intervention group
Group type: EXPERIMENTAL
Intervention: Eating breakfast
Number of subjects: 5145
Study 18375417 — intervention group
Group type: EXPERIMENTAL
Intervention: Meals/snacks per day
Number of subjects: 5145
Study 18375417 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast food meals per week
Number of subjects: 5145
Study 18375417 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight control practices (increasing fruits and vegetables, cutting out sweets, eating less high-carbohydrate foods)
Number of subjects: 5145
Study 18375417 — intervention group
Group type: COMPARATOR
Intervention: Self-weighing less than once per week
Number of subjects: 5145
Study 18375417 — intervention group
Group type: COMPARATOR
Intervention: More fast food meals consumed per week
Number of subjects: 5145
Study 18375417 — intervention group
Group type: COMPARATOR
Intervention: Fewer breakfast meals consumed per week
Number of subjects: 5145
Study 15637746 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with chronic constipation
Number of subjects: 70
Study 15637746 — intervention group
Group type: COMPARATOR
Intervention: Healthy children (control group)
Number of subjects: 70
Study 12789959 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-curing (heat conversion) with 35% hydrogen peroxide
Number of subjects: 20
Study 12789959 — intervention group
Group type: COMPARATOR
Intervention: No light-curing (no heat conversion) with 35% hydrogen peroxide
Number of subjects: 20
Study 7618021 — intervention group
Group type: EXPERIMENTAL
Intervention: Active (temazepam)
Number of subjects: 40
Study 7618021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 2650662 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine hydrochloride (Catapres)
Number of subjects: 8
Study 2650662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 21644 — intervention group
Group type: EXPERIMENTAL
Intervention: Melperone 100 mg X 3
Number of subjects: 63
Study 21644 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiothixene 10 mg X 3
Number of subjects: 63
Study 31444140 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 48
Study 31444140 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 48
Study 31334914 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal denervation
Number of subjects: 17
Study 31334914 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 17
Study 29077819 — intervention group
Group type: EXPERIMENTAL
Intervention: RAPP (Recovery Assessment by Phone Points)
Number of subjects: 0
Study 29077819 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 0
Study 26059463 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg IV)
Number of subjects: 10
Study 26059463 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 23822135 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation (CA) for long-standing persistent AF in women
Number of subjects: 220
Study 21683412 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator mid urethral sling
Number of subjects: 597
Study 21683412 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic mid urethral sling
Number of subjects: 597
Study 21683412 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest quartile of Valsalva leak point pressure (<86 cm H2O)
Number of subjects: 597
Study 21683412 — intervention group
Group type: EXPERIMENTAL
Intervention: Lowest quartile of maximum urethral closure pressure (<45 cm H2O)
Number of subjects: 597
Study 19559297 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhammosus GG (minimum dose, 10 degrees bacteria)
Number of subjects: 229
Study 19559297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 16432349 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA) 500 mg intravenously before operation followed by 250 mg every 6 hours for 3 days
Number of subjects: 214
Study 16432349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 15514192 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (25 mg per day)
Number of subjects: 508
Study 15514192 — intervention group
Group type: COMPARATOR
Intervention: Fosinopril (20 mg per day)
Number of subjects: 508
Study 15514192 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide plus Pravastatin (40 mg per day)
Number of subjects: 508
Study 15514192 — intervention group
Group type: COMPARATOR
Intervention: Fosinopril plus Pravastatin (40 mg per day)
Number of subjects: 508
Study 11759560 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% lidocaine injection
Number of subjects: 0
Study 11759560 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA cream
Number of subjects: 0
Study 11759560 — intervention group
Group type: EXPERIMENTAL
Intervention: Numby Stuff
Number of subjects: 0
Study 9548161 — intervention group
Group type: EXPERIMENTAL
Intervention: Triptorelin
Number of subjects: 49
Study 9548161 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 7996343 — intervention group
Group type: EXPERIMENTAL
Intervention: modified Herbst appliance (mHA)
Number of subjects: 6
Study 7996343 — intervention group
Group type: COMPARATOR
Intervention: muscle relaxation appliance (MR)
Number of subjects: 6